Page last updated: 2024-10-23

bencyclane and Leukemia P388

bencyclane has been researched along with Leukemia P388 in 1 studies

Bencyclane: A vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Its mechanism may involve block of calcium channels.

Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sitdikova, SM1
Donenko, FV1
Kabieva, AO1
Polotskiĭ, BE1
Moroz, LV1

Other Studies

1 other study available for bencyclane and Leukemia P388

ArticleYear
[Use of modifiers of multiple drug resistance to overcome tumor resistance to cytostatics in an in vivo system].
    Biulleten' eksperimental'noi biologii i meditsiny, 1996, Volume: 121, Issue:4

    Topics: Animals; Antibiotics, Antineoplastic; Bencyclane; Doxorubicin; Drug Resistance, Multiple; Drug Resis

1996